Document_and_Entity_Informatio
Document and Entity Information | 3 Months Ended | |
Mar. 31, 2015 | 6-May-15 | |
Document And Entity Information | ||
Entity Registrant Name | CANCER CAPITAL CORP | |
Entity Central Index Key | 1130889 | |
Document Type | 10-Q | |
Document Period End Date | 31-Mar-15 | |
Amendment Flag | FALSE | |
Current Fiscal Year End Date | -19 | |
Is Entity a Well-known Seasoned Issuer? | No | |
Is Entity a Voluntary Filer? | No | |
Is Entity's Reporting Status Current? | Yes | |
Entity Filer Category | Smaller Reporting Company | |
Entity Common Stock, Shares Outstanding | 6,150,000 | |
Document Fiscal Period Focus | Q1 | |
Document Fiscal Year Focus | 2015 |
Condensed_Balance_Sheets_Unaud
Condensed Balance Sheets (Unaudited) (USD $) | Mar. 31, 2015 | Dec. 31, 2014 |
CURRENT ASSETS | ||
Cash | $2,738 | $1,138 |
Total current assets | 2,738 | 1,138 |
Total assets | 2,738 | 1,138 |
CURRENT LIABILITIES | ||
Accounts payable - related party | 13,400 | 10,500 |
Notes payable - related party | 72,725 | 72,725 |
Notes payable | 69,525 | 64,525 |
Accrued interest - related party | 8,225 | 6,770 |
Accrued interest | 10,881 | 9,578 |
Total current liabilities | 174,756 | 164,098 |
Total liabilities | 174,756 | 164,098 |
STOCKHOLDERS' DEFICIT | ||
Common stock, $.001 par value; 20,000,000 shares authorized; 6,150,000 shares issued and outstanding | 6,150 | 6,150 |
Additional paid-in capital | 47,050 | 47,050 |
Accumulated deficit | -225,218 | -216,160 |
Total stockholders' deficit | -172,018 | -162,960 |
Total liabilities and stockholders' deficit | $2,738 | $1,138 |
Condensed_Balance_Sheets_Paren
Condensed Balance Sheets (Parenthetical) (USD $) | Mar. 31, 2015 | Dec. 31, 2014 |
Statement of Financial Position [Abstract] | ||
Common stock, par value | $0.00 | $0.00 |
Common stock, shares authorized | 20,000,000 | 20,000,000 |
Common stock, shares issued | 6,150,000 | 6,150,000 |
Common stock, shares outstanding | 6,150,000 | 6,150,000 |
Condensed_Statements_of_Operat
Condensed Statements of Operations (Unaudited) (USD $) | 3 Months Ended | |
Mar. 31, 2015 | Mar. 31, 2014 | |
Income Statement [Abstract] | ||
Revenues | ||
Expenses | ||
General and administrative | 6,300 | 6,300 |
Total expenses | 6,300 | 6,300 |
Net operating loss before other expense | -6,300 | -6,300 |
Other income (expense), non-operating | ||
Interest expense - related party | -1,455 | -1,060 |
Interest expense | -1,303 | -1,199 |
Total other income (expense) | -2,758 | -2,259 |
Loss from operations before income taxes | -9,058 | -8,559 |
Income taxes | ||
Net loss | ($9,058) | ($8,559) |
Basic and diluted net loss per share | $0 | $0 |
Weighted average shares outstanding | 6,150,000 | 6,150,000 |
Condensed_Statements_of_Cash_F
Condensed Statements of Cash Flows (Unaudited) (USD $) | 3 Months Ended | |
Mar. 31, 2015 | Mar. 31, 2014 | |
Cash Flows from Operating Activities | ||
Net loss | ($9,058) | ($8,559) |
Adjustments to reconcile net loss to cash provided (used) by operating activities: | ||
Expenses paid by related party | 2,900 | 2,800 |
Changes in assets and liabilities: | ||
Increase (decrease) in accounts payable and accrued expenses | 3,500 | |
Accrued interest - related party | 1,455 | 1,060 |
Accrued interest | 1,303 | 1,198 |
Net cash provided (used) by operating activities | -3,400 | -1 |
Cash Flows from Investing Activities | ||
Net cash provided by investing activities | ||
Cash Flows from Financing Activities | ||
Proceeds from advances and notes payable | 5,000 | 4,300 |
Net cash provided by financing activities | 5,000 | 4,300 |
Increase (decrease) in cash | 1,600 | 4,299 |
Cash and cash equivalents at beginning of period | 1,138 | 3,387 |
Cash and cash equivalents at end of period | $2,738 | $7,686 |
BASIS_OF_FINANCIAL_STATEMENT_P
BASIS OF FINANCIAL STATEMENT PRESENTATION | 3 Months Ended |
Mar. 31, 2015 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
BASIS OF FINANCIAL STATEMENT PRESENTATION | NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION |
The accompanying unaudited condensed financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted in accordance with such rules and regulations. The information furnished in the interim condensed financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements. Although management believes the disclosures and information presented are adequate to make the information not misleading, it is suggested that these interim condensed financial statements be read in conjunction with the Company’s audited financial statements and notes thereto included in its December 31, 2014 Annual Report on Form 10-K. Operating results for the three months ended March 31, 2015 are not necessarily indicative of the results to be expected for year ending December 31, 2015. |
GOING_CONCERN
GOING CONCERN | 3 Months Ended |
Mar. 31, 2015 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
GOING CONCERN | NOTE 2 – GOING CONCERN |
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has limited assets, has incurred losses since inception, has negative cash flows from operations, and has no revenue-generating activities. Its activities have been limited for the past several years and it is dependent upon financing to continue operations. These factors raise substantial doubt about the ability of the Company to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. It is management’s plan to acquire or merge with other operating companies. |
RECENT_PRONOUNCEMENT
RECENT PRONOUNCEMENT | 3 Months Ended |
Mar. 31, 2015 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
RECENT PRONOUNCEMENT | NOTE 3 - RECENT PRONOUNCEMENT |
On June 10, 2014, the Financial Accounting Standards Board ("FASB") issued update ASU 2014-10, Development Stage Entities (Topic 915). Amongst other things, the amendments in this update removed the definition of development stage entity from Topic 915, thereby removing the distinction between development stage entities and other reporting entities from US GAAP. In addition, the amendments eliminate the requirements for development stage entities to (1) present inception-to-date information on the statements of income, cash flows and shareholders’ equity, (2) label the financial statements as those of a development stage entity; (3) disclose a description of the development stage activities in which the entity is engaged and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. The amendments are effective for annual reporting periods beginning after December 31, 2014 and interim reporting periods beginning after December 15, 2015, however entities are permitted to early adopt for any annual or interim reporting period for which the financial statements have yet to be issued. The Company has elected to early adopt these amendments and accordingly have not labeled the financial statements as those of a development stage entity and have not presented inception-to-date information on the respective financial statements. |
SUBSEQUENT_EVENTS
SUBSEQUENT EVENTS | 3 Months Ended |
Mar. 31, 2015 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS | NOTE 4 – SUBSEQUENT EVENTS |
The Company has evaluated subsequent events from the balance sheet date through the date the financial statements were issued and has determined that there are no such events that would have a material impact on the financial statements. |